senior home health care - Oak Leaf Manor

The skilled nurse explains what the patient must need to consider.

4 min read

Senior Care

What is Senior Home Health Care? (3 In-Home Care Options)

June 1, 2021 olm0847

If your older loved one has a severe health condition, leaving them alone at...

Peer Support Platform Fello Secures $10.4M To Combat Loneliness Epidemic December 5, 2024

Fello’s $10.4 million raise includes a seed investment from Glen Tullman’s 62Ventures, The Capital Factory Fellowship Fund, Katalyst Capital and Offline Ventures. The post Peer Support Platform Fello Secures $10.4M To Combat Loneliness Epidemic appeared first on MedCity News.

Video: Battle of the Bulge – Wegovy vs. Zepbound December 4, 2024

The GLP-1 battle heats up with new preliminary data from Eli Lilly showing that patients using its weight loss drug Zepbound lost more weight on average in 72 weeks than those on Novo Nordisk’s Wegovy. The post Video: Battle of the Bulge – Wegovy vs. Zepbound appeared first on MedCity News.

Why One Investor Still Believes in Retail Health December 4, 2024

It’s been a tumultuous past couple years for retail health companies —but there are still reasons to believe in the convenient model that retail health offers, said Annie Lamont, managing partner and co-founder of Oak HC/FT. The post Why One Investor Still Believes in Retail Health appeared first on MedCity News.

Eli Lilly’s Zepbound Leads to Greater Weight Loss vs. Novo Nordisk Drug in Head-to-Head Test December 4, 2024

Eli Lilly obesity drug Zepbound led to 47% greater relative weight loss compared to Wegovy in a head-to-head clinical trial. The results could help Lilly differentiate its product from Novo Nordisk’s in the increasingly competitive market of obesity medications. The post Eli Lilly’s Zepbound Leads to Greater Weight Loss vs. Novo Nordisk Drug in Head-to-Head […]

A Biotech Startup’s Quest to Relieve Pulmonary Mucus Obstruction for Respiratory Care December 4, 2024

In response to emailed questions, the founders of MucoLife Therapeutics shared their company’s approach, which is designed to help people with COPD, cystic fibrosis, asthma, and pulmonary fibrosis. The post A Biotech Startup’s Quest to Relieve Pulmonary Mucus Obstruction for Respiratory Care appeared first on MedCity News.